tradingkey.logo

BioNexus Gene Lab Corp

BGLC
4.150USD
+0.050+1.22%
收盤 12/24, 13:00美東報價延遲15分鐘
7.46M總市值
虧損本益比TTM

BioNexus Gene Lab Corp

4.150
+0.050+1.22%

關於 BioNexus Gene Lab Corp 公司

BioNexus Gene Lab Corp. is a biotechnology company specializing in precision diagnostics and specialty chemical solutions. The Company, through its wholly owned subsidiary Chemrex Corporation Sdn. Bhd., focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its segments include Trading of industrial chemicals, Provision for genomic screening services, and Investment holding. The Provision for genomic screening services segment includes commercializing proprietary blood-based diagnostic test for early disease detection. Its subsidiary MRNA Scientific Sdn. Bhd owns algorithm software, technology, and know-how related to the detection of common diseases through blood analysis which it uses in its business.

BioNexus Gene Lab Corp簡介

公司代碼BGLC
公司名稱BioNexus Gene Lab Corp
上市日期Mar 11, 2020
CEOTan (Lee Su-Leng)
員工數量30
證券類型Ordinary Share
年結日Mar 11
公司地址10-2 Tower B, Vertical Business Suite
城市KUALA LUMPUR
上市交易所NASDAQ OMX - NASDAQ BASIC
國家Malaysia
郵編59200
電話13072416898
網址https://www.bionexusgenelab.com/
公司代碼BGLC
上市日期Mar 11, 2020
CEOTan (Lee Su-Leng)

BioNexus Gene Lab Corp公司高管

名稱
名稱/職務
職務
持股
持股變動
Ms. Jook Yuen Low
Ms. Jook Yuen Low
Independent Director
Independent Director
1.26K
-0.08%
Ms. Hua Yew Chak
Ms. Hua Yew Chak
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Ms. Meng Wong Yee
Ms. Meng Wong Yee
Director
Director
--
--
Mr. Lee Su-Leng Tan
Mr. Lee Su-Leng Tan
President, Chief Executive Officer, Chief Operating Officer
President, Chief Executive Officer, Chief Operating Officer
--
--
Mr. Teong Teoh Boon
Mr. Teong Teoh Boon
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Chi Yuen (George) Leong
Mr. Chi Yuen (George) Leong
Director
Director
--
--
Mr. Ping Lin Chai
Mr. Ping Lin Chai
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Teng Fook Fong
Mr. Teng Fook Fong
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Min Fong Yeat
Mr. Min Fong Yeat
Chairman of the Board
Chairman of the Board
--
--
Mr. Chee Keong Yap
Mr. Chee Keong Yap
Independent Non-Executive Director
Independent Non-Executive Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Ms. Jook Yuen Low
Ms. Jook Yuen Low
Independent Director
Independent Director
1.26K
-0.08%
Ms. Hua Yew Chak
Ms. Hua Yew Chak
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Ms. Meng Wong Yee
Ms. Meng Wong Yee
Director
Director
--
--
Mr. Lee Su-Leng Tan
Mr. Lee Su-Leng Tan
President, Chief Executive Officer, Chief Operating Officer
President, Chief Executive Officer, Chief Operating Officer
--
--
Mr. Teong Teoh Boon
Mr. Teong Teoh Boon
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Chi Yuen (George) Leong
Mr. Chi Yuen (George) Leong
Director
Director
--
--

收入明細

由於公司未披露,未能獲取相關數據
由於公司未披露,未能獲取相關數據
業務
地區
由於公司未披露,未能獲取相關數據

股東統計

更新時間: 12月6日 週六
更新時間: 12月6日 週六
持股股東
股東類型
持股股東
持股股東
佔比
Fidelion Diagnostics Pte Ltd
16.60%
ARC Group Ltd
7.40%
Liew (Choong-Chin)
7.05%
Lai (Soo Kow(kenny))
5.29%
DRW Securities, LLC
0.62%
其他
63.04%
持股股東
持股股東
佔比
Fidelion Diagnostics Pte Ltd
16.60%
ARC Group Ltd
7.40%
Liew (Choong-Chin)
7.05%
Lai (Soo Kow(kenny))
5.29%
DRW Securities, LLC
0.62%
其他
63.04%
股東類型
持股股東
佔比
Corporation
24.00%
Individual Investor
12.39%
Investment Advisor
0.94%
其他
62.67%

機構持股

更新時間: 12月8日 週一
更新時間: 12月8日 週一
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
14
22.28K
1.52%
--
2025Q3
14
22.28K
2.00%
+12.71K
2025Q2
13
9.56K
1.47%
-6.24K
2025Q1
13
15.80K
1.33%
-8.09K
2024Q4
12
17.81K
1.26%
+4.78K
2024Q3
9
13.03K
0.67%
+6.46K
2024Q2
7
6.57K
0.88%
-3.53K
2024Q1
7
10.10K
0.59%
-313.00
2023Q4
6
10.42K
1.15%
-9.94K
2023Q3
5
20.36K
0.00%
+20.36K
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Liew (Choong-Chin)
166.67K
9.28%
--
--
Feb 27, 2025
Lai (Soo Kow(kenny))
125.00K
6.96%
--
--
Feb 27, 2025
UBS Financial Services, Inc.
9.56K
0.53%
+9.56K
--
Jun 30, 2025
Low (Jook Yuen)
1.26K
0.07%
--
--
Feb 27, 2025
Blackstone Alternative Investment Advisors LLC
3.00
0%
--
--
Jun 30, 2025
查看更多

持股ETF

機構名稱
佔比
暫無數據

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
類型
比率
Apr 03, 2025
Merger
10→1
公告日期
類型
比率
Apr 03, 2025
Merger
10→1

常見問題

BioNexus Gene Lab Corp的前五大股東是誰?

BioNexus Gene Lab Corp的前五大股東如下:
Liew (Choong-Chin)
持有股份:166.67K
佔總股份比例:9.28%。
Lai (Soo Kow(kenny))
持有股份:125.00K
佔總股份比例:6.96%。
UBS Financial Services, Inc.
持有股份:9.56K
佔總股份比例:0.53%。
Low (Jook Yuen)
持有股份:1.26K
佔總股份比例:0.07%。
Blackstone Alternative Investment Advisors LLC
持有股份:3.00
佔總股份比例:0.00%。

BioNexus Gene Lab Corp的前三大股東類型是什麼?

BioNexus Gene Lab Corp 的前三大股東類型分別是:
Fidelion Diagnostics Pte Ltd
ARC Group Ltd
Liew (Choong-Chin)

有多少機構持有BioNexus Gene Lab Corp(BGLC)的股份?

截至2025Q4,共有14家機構持有BioNexus Gene Lab Corp的股份,合計持有的股份價值約為22.28K,占公司總股份的1.52% 。與2025Q3相比,機構持股有所增加,增幅為-0.48%。

哪個業務部門對BioNexus Gene Lab Corp的收入貢獻最大?

在--,--業務部門對BioNexus Gene Lab Corp的收入貢獻最大,創收--,占總收入的--% 。
KeyAI